Free Trial
NASDAQ:CANC

Tema Oncology ETF (CANC) Price, Holdings, & News

$26.68 +0.29 (+1.08%)
Closing price 08/15/2025 03:25 PM Eastern
Extended Trading
$26.68 0.00 (0.00%)
As of 08/15/2025 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Tema Oncology ETF (NASDAQ:CANC)

Key Stats

Today's Range
$26.44
$26.87
50-Day Range
$24.53
$26.94
52-Week Range
$20.10
$30.11
Volume
2,251 shs
Average Volume
15,512 shs
Market Capitalization
$69.65 million
Assets Under Management
$69.41 million
Dividend Yield
2.70%
Net Expense Ratio
0.75%
Aggregate Rating
Moderate Buy

ETF Overview

Tema Oncology ETF Expenses

TypeCANCTheme ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.99%0.57%0.56%0.54%0.53%
Other Expenses0.00%0.57%0.56%0.52%0.56%
Total Expense0.99%0.74%0.76%0.73%0.73%
Fee Waiver-0.24%-0.76%-0.66%-0.50%-0.63%
Net Expense0.75%0.60%0.63%0.63%0.60%
Receive CANC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tema Oncology ETF and its competitors with MarketBeat's FREE daily newsletter.

CANC ETF News Headlines

No headlines for this company have been tracked by MarketBeat.com

CANC ETF - Frequently Asked Questions

Tema Oncology ETF's stock was trading at $24.31 at the start of the year. Since then, CANC stock has increased by 9.8% and is now trading at $26.6850.

Tema Oncology ETF's top institutional shareholders include Jane Street Group LLC (0.54%).

Shares of CANC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tema Oncology ETF investors own include Archer Aviation (ACHR), Advanced Micro Devices (AMD), Beam Therapeutics (BEAM), CRISPR Therapeutics (CRSP), Lockheed Martin (LMT), Nice (NICE) and Intellia Therapeutics (NTLA).

Fund Details

Issuer
Tema Global
Fund Name
Tema Oncology ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:CANC
Inception Date
8/15/2023
Fund Manager
David Song
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Developed Markets
Region
Global
Number of Holdings
53

Fund Statistics

Assets Under Management
$69.41 million
Average Daily Volume
$0.00
Discount/Premium
0.01%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Tema Global Limited
Custodian
U.S. Bank, N.A.
Distributor
Foreside Fund Services, LLC
Transfer Agent
U.S. Bancorp Fund Services, LLC
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
N/A
Short Interest
16,900 shs

Miscellaneous

Beta
1.11
Creation Unit
10,000
Creation Fee
$500.00
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Top 10 CANC Holdings

CANC Sector Exposure

CANC Industry Exposure


This page (NASDAQ:CANC) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners